Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

A multiplex platform for the identification of ovarian cancer biomarkers

10 Oct 2017

Abstract excerpt

BACKGROUND: Currently, there are no FDA approved screening tools for detecting early stage ovarian cancer in the general population. Development of a biomarker-based assay for early detection would significantly improve the survival of ovarian cancer patients. METHODS: Multiplex Oncology Plates) can simultaneously measure the expression of 92 proteins in serum based on a proximity extension assay. We analyzed...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Advanced Biosensing Techniques and Applications
Share to Advanced Proteomics Techniques and Applications
Share to Ovarian cancer diagnosis and treatment

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 29051715
DOI: 10.1186/s12014-017-9169-6

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

A multiplex platform for the identification of ovarian cancer biomarkersPMID 29051715Read ↗

High throughput proteomics identifies a high-accuracy 11 plasma protein biomarker signature for ovarian cancerSemantic proximity Read ↗

An overview of biomarkers for the ovarian cancer diagnosis.Semantic proximity Read ↗

Ovarian cancer biomarkers for molecular biosensors and translational medicine.Semantic proximity Read ↗

Multi-biomarker panel signature as the key to diagnosis of ovarian cancerSemantic proximity Read ↗

Multi-analyte approach combining cfDNA sequencing and protein testing for early ovarian cancer detectionSemantic proximity Read ↗

Added value of serum proteins to clinical and ultrasound information in predicting the risk of malignancy in ovarian tumorsSemantic proximity Read ↗

Discovery and preliminary validation of a new panel of personalized ovarian cancer biomarkers for individualized detection of recurrenceSemantic proximity Read ↗

An Integrated Clinical-Genomics Approach Identifies a Candidate Multi-Analyte Blood Test for Serous Ovarian CarcinomaSemantic proximity Read ↗

Discovery of serum biomarkers of ovarian cancer using complementary proteomic profiling strategiesSemantic proximity Read ↗

Using protein microarray to identify and evaluate autoantibodies to tumor‐associated antigens in ovarian cancerSemantic proximity Read ↗

Applications of Proteomics in Ovarian Cancer: Dawn of a New EraSemantic proximity Read ↗

Early Detection of Ovarian Cancer Using Cell-Free DNA Fragmentomes and Protein BiomarkersSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.